FDA clears Medtronics stent for use in iliac arteries

Justine Varieur Cadet | | Health Imaging | Screening
Medtronic has received FDA approval for the Complete SE vascular stent system to be used for the treatment of peripheral arterial disease in the iliac arteries.

The Complete SE vascular stent system features a dual-deployment delivery system with a triaxial design, according to the Minneapolis-based company. The new delivery system is made up of an inner shaft, a retractable sheath and a stabilizing sheath.

Robert Molnar, MD, of Michigan Vascular Research Center in Flint, and William Gray, MD, director of endovascular intervention at New York-Presbyterian Hospital/Columbia University Medical Center in New York City, led the study (as co-principal investigators) that contributed to this approval.

Justine Varieur Cadet

Related Content

Rising rates of interval breast cancers have experts calling for more risk-based screenings
Rates of breast cancer diagnosis, death expected to climb in coming decades
AI quantifies breast arterial calcifications on mammograms
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
American College of Radiology announces significant expansion of Lung Cancer Screening Registry
AI beats standard regression models at predicting lung cancer risk

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.